Barclays’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,800
| Closed | -$4K | – | 7258 |
|
|
2016
Q4 | $4K | Buy |
1,800
+1,600
| +800% | +$4.46K | ﹤0.01% | 6235 |
|
|
2016
Q3 | $1K | Sell |
200
-55,700
| -100% | -$177K | ﹤0.01% | 6559 |
|
|
2016
Q2 | $176K | Sell |
55,900
-14,000
| -20% | -$46.7K | ﹤0.01% | 4009 |
|
|
2016
Q1 | $210K | Buy |
69,900
+66,000
| +1,692% | +$206K | ﹤0.01% | 3818 |
|
|
2015
Q4 | $12K | Buy |
3,900
+2,300
| +144% | +$9.63K | ﹤0.01% | 5365 |
|
|
2015
Q3 | $8K | Buy |
1,600
+200
| +14% | +$1.15K | ﹤0.01% | 5899 |
|
|
2015
Q2 | $8K | Sell |
1,400
-6,700
| -83% | -$44.9K | ﹤0.01% | 6244 |
|
|
2015
Q1 | $57K | Buy |
8,100
+400
| +5% | +$2.9K | ﹤0.01% | 5193 |
|
|
2014
Q4 | $54K | Buy |
7,700
+1,900
| +33% | +$15K | ﹤0.01% | 5669 |
|
|
2014
Q3 | $41K | Sell |
5,800
-90,300
| -94% | -$838K | ﹤0.01% | 6040 |
|
|
2014
Q2 | $865K | Sell |
96,100
-105,600
| -52% | -$941K | ﹤0.01% | 3468 |
|
|
2014
Q1 | $1.61M | Sell |
201,700
-96,200
| -32% | -$825K | ﹤0.01% | 2760 |
|
|
2013
Q4 | $2.38M | Buy |
297,900
+51,400
| +21% | +$433K | ﹤0.01% | 2486 |
|
|
2013
Q3 | $1.73M | Buy |
246,500
+193,100
| +362% | +$1.55M | ﹤0.01% | 2759 |
|
|
2013
Q2 | $412K | Buy |
+53,400
| New | +$416K | ﹤0.01% | 4442 |
|
